Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up

Stagecoach Share Price (SGC)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 117.20on 19-04-2019 at 16:30:00
Change 0.00 0.00%
Buy 117.50
Sell 117.30
Buy / Sell SGC Shares
Sponsored Financial Content
Last Trade: Sell 500 at 117.20p
Day's Volume: 0
Last Close: 117.20p
Open: 0.00p
Day's Range 0.00p - 0.00p
52wk Range: 113.90p - 184.70p
Market Capitalisation: £670m
VWAP: 0.00p
Shares in Issue: 572m

Recent Trades History Stagecoach (SGC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell*500117.2017:08:51 - 18-Apr-19
Sell*5,062117.19517:06:48 - 18-Apr-19
Buy*1,838117.79817:01:19 - 18-Apr-19
Sell*3,250117.19416:53:09 - 18-Apr-19
Buy*1,100117.7416:39:00 - 18-Apr-19
Buy*1,100117.7416:39:00 - 18-Apr-19
Sell*1,100117.39616:39:00 - 18-Apr-19
Sell*1,100117.396Uncrossing Trade
16:39:00 - 18-Apr-19
Sell*272,678117.20Automatic Execution
16:35:26 - 18-Apr-19
Sell*46117.3016:29:46 - 18-Apr-19

Share Price History for Stagecoach

Time period:
Date Open High Low Close Volume
19th Apr 2019 (Fri)
18th Apr 2019 (Thu)117.50119.00116.90117.90901,203
17th Apr 2019 (Wed)121.50121.50117.900.00728,651
16th Apr 2019 (Tue)119.00121.30117.90120.701,325,010
15th Apr 2019 (Mon)119.70136.00118.80133.302,264,511
12th Apr 2019 (Fri)119.70136.00118.80133.302,264,511
11th Apr 2019 (Thu)119.70136.00118.80133.302,264,511
10th Apr 2019 (Wed)119.70136.00118.80133.302,264,511
9th Apr 2019 (Tue)134.50138.10131.10137.201,187,489
8th Apr 2019 (Mon)137.00139.30133.20138.901,339,167
5th Apr 2019 (Fri)145.40145.50135.50147.502,423,135
4th Apr 2019 (Thu)157.40158.10146.50160.203,101,599
3rd Apr 2019 (Wed)170.00174.70158.30154.801,642,965
2nd Apr 2019 (Tue)155.50155.50151.70153.90299,754
1st Apr 2019 (Mon)149.80153.90149.70153.60535,146
29th Mar 2019 (Fri)157.20157.20151.50155.50496,020
28th Mar 2019 (Thu)156.30158.00154.30155.80410,824
27th Mar 2019 (Wed)156.00156.00154.00155.20643,421
26th Mar 2019 (Tue)156.40157.60155.10155.70651,347
25th Mar 2019 (Mon)157.10157.20154.80158.50382,317
22nd Mar 2019 (Fri)164.50164.50158.10161.60316,884
21st Mar 2019 (Thu)161.10162.20159.00160.50409,091

SGC - Stagecoach Investor Summary

This company is currently the market leader in 'green' travel and has operations throughout the UK, North America and Canada. It has spent the last few years using innovative technologies and smart investments to steer the growth of the company and is now dedicated to improving the environmental impact that public transport has. Since 2007 Stagecoach Group PLC has developed the first bio-buses that run exclusively on bio-diesel, the first carbon neutral bus network and a number of state-of-the-art energy efficient facilities and waste recycling sites. Not bad from a company that only started 28 years ago with just two buses.

Currently the Stagecoach Group operate successful bus, rail and tram services in the UK and a leading long distance coach service in North America and Canada. Their buses run in over 100 towns and cities throughout the UK and are estimated to own a 14% share of the UK bus market. Their rail operations include South Western Trains and East Midland Trains whilst their tram services include the Sheffield Supertram and the Manchester Metrolink. In total, the company now have around 25% of the UK rail market and because of a partnership with Virgin trains and the West Coast line this is set to grow further. The Stagecoach Group believe that complimentary acquisitions help to safeguard their share price and maximise their shareholders' profits so the company regularly buy what they see to be potential growth opportunities within the UK and occasionally throughout the world.

News about Stagecoach (SGC)

Miners Help FTSE Recover

News - Sunday, April 21, 2019

The FTSE 100 recovered from a five month low on Thursday, thanks in part to a gold rally which saw miners stage a significant rally....

FTSE Boosted By AstraZeneca

News - Sunday, April 21, 2019

The FTSE 100 ended the week on a high note, benefiting from a strong performance by AstraZeneca after the drug company reported that its recent trial of a cancer drug had showed promising results. The company was trialling an immunotherapy drug called Imfinzi, which it had found could lower the risk of stage III lung cancer worsening or becoming fatal....

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered